Inhibition by oral N-acetylcysteine of doxorubicin-induced clastogenicity and alopecia, and prevention of primary tumors and lung micrometastases in mice

International Journal of Oncology

Volumn 13, Issue 2, 1998, Pages 217-224

  D'Agostini, Francesco ^a   Bagnasco, Maria ^a   Giunciuglio, Daniela ^b   Albini, Adriana ^b   De Flora, Silvio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Alopecia; Cancer invasion and metastasis; Cancer prevention; Clastogenicity; Doxorubicin; N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; DOXORUBICIN;

ALOPECIA; ANIMAL MODEL; ARTICLE; BLOOD TOXICITY; BODY WEIGHT; CANCER INVASION; CARDIOTOXICITY; CONTROLLED STUDY; DRUG POTENTIATION; ERYTHROCYTE; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0031849623     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.2.217     Document Type: Article

References (40)

1. Kohn EC and Liotta LA: Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55: 1856-1862, 1995.
2. Teicher BA, Holden SA, Ara G, Alvarez Sotomayor E, Huang ZD, Chen Y-N and Brem H: Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other antiangiogenic agents. Int J Cancer 57: 920-925, 1994.
3. Anderson IC, Shipp MA, Dochcrty AJP and Teicher BA: Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma. Cancer Res 56: 715-718, 1996.
4. De Flora S, D'Agostini F, Masiello L, Giunciuglio D and Albini A: Synergism between N-acetylcysteine and doxorubicin in the prevention of tumorigenicity and metastasis in murine models. Int J Cancer 67: 842-848, 1996.
5. Kelloff GJ, Crowell JA, Boone CW, Steele VE, Lubet RA, Greenwald P, Alberts DS, Covey JM, Doody LA, Knapp GG, Nayfield S, Parkinson DR, Prasad VK, Prorok PC, Sausville EA and Sigman CC: Clinical development plans for cancer chemopreventive agents: N-acetyl-L-cysteine. J Cell Biochem 20 (Suppl.): 63-73, 1994.
6. De Flora S, Balansky RM, Bennicclli C, Camoirano A, D'Agostini F, Izzotti A and Cesarone CF: Mechanisms of anticarcinogenesis: the example of N-acctyleysteine. In: Drugs, Diet and Disease. Vol. 1. Mechanistic Approaches to Cancer. Ioannides C and Lewis DFV (eds). Horwood Ellis, Hemel Hempstead, pp151-203, 1995.
7. De Flora S, Cesarone CF, Balansky RM, Albini A, D'Agostini F, Bennicelli C, Bagnasco M, Camoirano A, Scatolini L, Rovida A and Izzotti A: Chemopreventive properties and mechanisms of N-acctylcysteine. The experimental background. J Cell Biochem 22 (Suppl.): 33-41, 1995.
8. Kalebic T, Masiero L, Onista M and Garbisa S: HIV-I modulates the expression of gelatinase A and B in monocytic cells. Biochem Biophys Res Commun 205: 1243-1249, 1994.
9. Albini A, D'Agostini F, Giunciuglio D, Paglieri I, Balansky RM and De Flora S: Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetyIcysteine. Int J Cancer 61: 121-129, 1995.
10. Lafon C, Mathieu C, Guerrin M, Pierre O, Vidai S and Valette A: Transforming growth factor ß1-induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-acetylcysteine and bcl-2. Cell Growth Differ 7: 1095-1104, 1996.
11. Carter SK: Adriamycin. A review. J Natl Cancer Inst 55: 1265-1274, 1975.
12. Arcamone F: Properties of antitumor anthracyclines and new developments in their application. Cancer Res 45: 5995-5999, 1985.
13. Olson RD, MacDonald JS, van Boxtel CJ, Boerth RC, Harbison RD, Slonim AE, Freeman RW and Oates JA: Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin. J Pharmacol Exp Ther 215: 450-454, 1980.
14. Doroshow JH, Locker JY, Ifrim I and Myers CE: Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J Clin Invest 68; 1053-1064, 1981.
15. Graeff AS and Scheulen ME: Prevention of adriamycin cardiotoxicity by niacin, isocitrate or N-acetylcysteine in mice. A morphological study. Pathol Res Pract 181: 168-174, 1986.
16. Mavournin KH, Blakey DH, Cimino MC, Salamone MF and Heddle JA: The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res 239: 29-80, 1990.
17. Stetler-Stevenson GW, Krutzsch H, Wacher M, Margulies MK and Liotta LA: The activation of human type IV collagnease proenzyme. J Biol Chem 264: 1535-1536, 1989.
18. Melchiori A, Albini A, Ray JM and Stetler-Stevenson WG: Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. Cancer Res 52: 2353-2356, 1992.
19. Devary Y, Gottlieb RA, Lau LF and Karin M: Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 11: 2804-2811, 1991.
20. Pinkus R, Bergelson S and Daniel V: Phenobarbital induction of AP-1 binding activity mediates activation of glutathione S-transferase and quinone reductase gene expression. Biochem J 290: 637-640, 1993.
21. Bergelson S, Pinkus R and Daniel V: Intracellular glutathione levels regulate/fos/jun induction and activation of glutathione S-transferase gene expression. Cancer Res 54: 36-40, 1994.
22. Angel P and Karin M: The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation. Biochem Biophys Acta 1072: 129-157, 1991.
23. Janssen YM, Heintz NH and Mossman BT: Induction of c-fos and c-jun proto-oncogene expression by asbestos is ameliorated by W-acetyl-L-cysteine in mesothelial cells. Cancer Res 55: 2085-2089, 1995.
24. De Flora S, Bennicelli C, Zanacchi P, D'Agostini F and Camoirano A: Mutagenicity of active oxygen species in bacteria and its enzymatic or chemical inhibition. Mutat Res 214: 153-158, 1989.
25. Camoirano A, De Flora S and Dahl T: Genotoxicity of volatile and secondary reactive oxygen species generated by photosensitization. Environ Mol Mutagen 21: 219-228, 1993.
26. 32P postlabeling. Free Radic Res 28: 165-178, 1998.
27. Nowak D and Drzewoski J: Anthracycline-induced oxidative stress - its role in the development of cardiac damage. Cancer J 9: 296-303, 1996.
28. Sandoval C, Pui CH, Bowman LC, Heaton D, Hunwitz CA, Raimondi SC, Behm FG and Head DR: Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase-II inhibitors, and irradiation. J Clin Oncol 11: 1039-1045, 1993.
29. Malkinson FD, Geng L and Hanson WR: Prostaglandins protect against murine hair injury produced by ionizing radiation or doxorubicin. J Invest Dermatol 101 (Suppl. 1): I35S-137S, 1993.
30. Powis G and Kooistra KL: Doxorubicin-induced hair loss in the Angora rabbit: a study of treatments to protect against the hair loss. Cancer Chemother Pharmacol 20: 291-296, 1987.
31. Hussein AM, Jimenez JJ, McCall CA and Yunis AA: Protection from chemotherapy-induced alopecia in a rat model. Science 249: 1564-1566, 1990.
32. Bogovski P: Tumours of the skin. In: Pathology of Tumours in Laboratory Animals. Vol. II. Tumours of the Mouse. Turusov VS and Mohr U (eds). IARC Scientific Publ. No. 111, Lyon, pp 1-45, 1994.
33. Sohn SJ, Huh IH, Choi SG and Heo MY: Suppresive effect of N-acetylcysteine on the adriamycin-induced micronuclei formation in bone marrow cells. Yakhak Hoechi (in Korean) 37: 278-285, 1993.
34. De Flora S, Camoirano A, Izzotti A, Zanacchi P, Bagnasco M and Cesarone CF: Antimutagenic and anticarcinogenic mechanisms of aminothiols. In: Anticarcinogenesis and Radiation Protection III. Nygaard F and Upton AC (eds). Plenum Press, New York, pp275-285, 1991.
35. Jimenez JJ, Huang H-S and Yunis AA: Treatment with ImuVert/N-acetylcysteine protects rats from cyclophosphamide/ cytarabine-induced alopecia. Cancer Invest 10: 271-276, 1992.
36. Freeman RW, MacDonald JS, Olson RD, Boerth RC, Oates JA and Harbison RD: Effect of sulfhydryl-containing compounds on the antitumor effects of adriamycin. Toxicol Appl Pharmacol 54: 168-175, 1980.
37. Imamura F, Horai T, Mukai M, Shinkai K and Akedo K: Potentiation of invasive capacity of rat ascites hepatoma cells by adriamycin. Cancer Res 50: 2018-2021, 1990.
38. Repesh LA, Drake SR, Warner MC, Downing SW, Jyring R, Seftor EA, Hendrix MJ and McCarthy JP: Adriamycin-induced inhibition of melanoma cell invasion is correlated with decreases in tumor cell motility and increases in focal contact formation. Clin Exp Metastasis 11: 91-102, 1993.
39. Supino R, Cecchi C, Mapelli E and Sanfilippo O: Modification of invasion and differentiation in human melanoma cell clones. Melanoma Res 4: 251-257, 1994.
40. Aruoma OI, Halliwell B, Hoeg BM and Butler J: The antioxidant action of N-acetylcysteine. Free Radie Biol Med 6: 593-597, 1989.